SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-141843
Filing Date
2024-05-17
Accepted
2024-05-17 17:00:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d841555ddefa14a.htm DEFA14A 13008
  Complete submission text file 0001193125-24-141843.txt   14108
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38662 | Film No.: 24961074
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)